Introduction. e aim of the study was to determine intubation conditions in the patients receiving rocuronium in comparison to succinylcholine for rapid sequence intubation during the induction of anesthesia for operative management of bowel obstruction. Methods. In the randomized controlled study 30 adult patients with bowel obstruction undergoing urgent surgery were randomly allocated in two groups. For muscle relaxation the S-group of patients received succinylcholine (1.5 mg/kg) and the Rgroup rocuronium (1.2 mg/kg). Intubation conditions were evaluated using a grading system according to Viby-Morgenson. Primary outcomes were intubation conditions 1 minute a er the application of a muscle relaxant. Secondary outcome measures were heart rate, blood pressure, and pulse oximetry; potassium and myoglobin serum level. Results. All patients were orotracheally intubated in the rst attempt. During induction, we didn't observe vomiting or aspiration. Overall intubation conditions in the S-group were statistically signi cantly better than in the R-group. A er RSI there was a statistically signi cant decrease in systolic and diastolic blood pressure in both groups and statistically signi cant decrease in heart rate in the S-group. A er RSI the potassium level in the S-group was signi cantly higher in comparison to the R-group and serum myoglobin level nonsigni cantly increased in the S-group and statistically signi cantly decreased in the R-group.
INTRODUCTION
Bowel obstruction is a common surgical emergency o en requiring urgent operative management (1) . Patients with bowel obstruction have an increased risk of vomiting and pulmonary aspiration of gastric content and require rapid sequence intubation (RSI) during the induction of anesthesia (2) (3) (4) . RSI is a well-de ned medical procedure used in urgent airway management in critically ill patients and during the induction of anesthesia (4 -8) .
e most commonly used muscle relaxant to perform RSI in the past and still today is the depolarizing muscle relaxant succinylcholine because of its excellent pharmacokinetic features (9, 10) . Succinylcholine has a rapid onset and short duration of action. In case of di cult or failed orotracheal intubation, muscle relaxation is rapidly resolved; the patient starts breathing spontaneously, and the risk of pulmonary aspiration is reduced. Unfortunately, succinylcholine can cause several adverse side e ects a ecting blood pressure and heart rate, causing fasciculations, muscle pain and prolonged paralysis, elevated intragas-tric, intraocular and intracranial pressure, hyperkalemia, masseter muscle rigidity, malignant hyperthermia, generalized contractions, and histamine release (3, (11) (12) (13) . Rocuronium is a non-depolarizing muscle relaxant with rapid onset of action and fewer side e ects than succinylcholine (10, 11, 13, 14, 16) . At a higher dose it has an onset of action that approaches succinylcholine, making it a suitable alternative for RSI. Even though rocuronium has a longer duration of action, neuromuscular block can be neutralized with sugammadex in the case of a failed RSI, even when neuromuscular block is deep (11, 15 -18) . Rocuronium has much less side e ects compared to succinylcholine, particularly in critically ill patients with bowel obstruction (3, 11) . However, the quality of vocal cord visualization, which is crucial for successful orotracheal intubation, is better with succinylcholine (19) . Succinycholine and rocuronium can cause anaphylactic reaction, but using succinycholine for RSI carries almost twice the greater risk for anaphylactic reaction compared to rocuronium (38) . e aim of the study was to compare intubation conditions in patients receiving rocuronium in comparison with patients receiving succinylcholine for RSI during the induction of anesthesia for operative management of bowel obstruction. All patients provided a signed informed consent before randomization. Adults older than 18 years with the American Society of Anesthesiology physical (ASA) status classes 2 and 3, who had bowel obstruction and were scheduled for an urgent surgery at the University Medical Centre Maribor between December 2013 and June 2016, were enrolled in the randomized controlled study. e exclusion criteria were increased serum potassium level, severe acute or chronic renal failure, Mallampaty score 3 or 4, and history of allergy to any of medications used in our protocol, patient ASA score more than 3 and patient refusing to participate in the study. Patients were randomly allocated before surgery to either the succinylcholine group (S-group) or rocuronium group (R-rocuronium), using the random number generator (21). (http://193.2.12.193/generator/ generator.html)
METHODS

Anesthetic management
Patients did not receive any premedication. In the operating room the nasogastric tube and peripheral venous catheter 16-G were inserted. e gastric content was aspirated through the nasogastric tube as much as possible. e patients were preoxygenated through the facemask with a ow of 10l/ min for 5 minutes. Before the induction of anesthesia, patients were monitored with electrocardiography, noninvasive blood pressure measurement, and pulse oximetry. Radial artery line was inserted and the relaxometer TOF-Watch S (Organon) was initiated on the opposite side of the arterial catheter. Patients received a bolus of midazolam 0.05mg/kg body weight (b.w.) and fentanyl 2 µg/kg b.w. before the relaxometer was calibrated. A er calibration in the Rgroup, TOF was measured 60 seconds a er muscular relaxant application. e patients were positioned in the head-down position and the gastric content was once again aspirated. e induction of anesthesia and orotracheal intubation was performed according to the RSI protocol. e induction to the anesthesia was continued with etomidate 0.3mg/kg b.w. Patients in the S-group received succinylcholine 1.5mg/kg b.w. and the patients in R-group received rocuronium 1.2mg/kg b.w. e Selick maneuver was performed. Indirect laryngoscopy and orotracheal intubation with Macintosh laryngoscope was performed 60 seconds a er the induction.
Data collection
We collected patients demographic data (age, sex, height, weight), ASA status and hemodynamic measurements 1 minute before the induction and 1 minute a er orotracheal intubation (blood pressure, heart rate and pulse oximetry), clinical intubating conditions (assessed by the anesthesiologist), intubating conditions according to the Viby-Morgenson score system (table  1) , number of orotracheal intubation attempts, vomiting, aspiration, oropharyngeal and laryngeal pain a er extubation. Blood samples for serum potassium and myoglobin measurement were collected through a radial artery line before the induction of anesthesia and 5 minutes a er the muscular relaxant application.
Study outcomes
Primary outcomes were intubation conditions 1 minute a er the muscular relaxant application, determined by response to laryngoscopy, vocal cord position and movement, and response to intubation. Secondary outcome measures were: heart rate, blood pressure and pulse oximetry, measured 1 minute before and a er the orotracheal intubation; potassium and myoglobin serum level measured 5 minute before and a er the muscle relaxant application.
Statistics
Data were analyzed with the IBM SPSS Statistics statistical so ware version 19.0 (SPSS Inc., Chicago, IL, USA). Patients' characteristics and baseline values were compared using a t-test for independent samples, the Kruskal Wallis test, and χ2 where appropriate. e t-test for independent samples was performed to compare the hemodynamic data between the two groups and t-test for paired samples to compare the hemodynamic data before and a er intubation with baseline values. Data are presented as mean value ± standard deviation (SD). P ≤ 0.05 was considered statistically signi cant.
RESULTS
We enrolled 46 patients with bowel obstruction who underwent urgent operative management and RSI during the induction of anesthesia. Sixteen patients were excluded from the study due to increased serum potassium, renal failure, increased Mallampaty, and ASA score.
irty patients were randomly allocated into S-group or R-group ( Figure 1 ). ere were no statistically signi cant differences between both groups according to main demographic characteristics Table 2 . All patients in both groups were orotracheally intubated in the rst attempt. During RSI no vomiting or aspiration occurred in any of the patients. Overall intubation conditions in both groups are listed in Table 3 , according to the grading system for intubation (Table  1) . Intubation conditions in S-group were excellent in 80% of patients and good in 20% of patients. In R-group, intubation conditions were excellent in 40% of patients and good in 60% of patients. In both groups we did not observe any patients with poor intubation conditions. Intubation conditions in S-group were statistically signi cantly better than in R-group of patients (Table 3) .
ere were no statistically signi cantly di erences between groups comparing individual parameters which determine overall intubating conditions according to the grading system score designed by Viby-Morgenson et al. (Table 4; 22) . In both groups we observed no resistance to laryngoscopy (Table 4 ). We observed better vocal cord position in the S-group, which was not statistically signi cant. In the R-group we observed one reaction to intubation with a slight limb movement and one movement of vocal cords during orotracheal intubation (Table 4) ere were no statistically signi cant differences in systolic and diastolic blood pressure before and a er RSI between the groups (table 5). ere was a statistically signi cant decrease in the systolic and diastolic blood pressure a er RSI in both groups (table 5) . Before RSI there were no signi cant di erences in the heart rate between the groups. A er RSI, there was a statistically signicant decrease in the heart rate in the Sgroup, while in the R-group we observed a small increase in the heart rate, which was not statistically signi cant (table 5) .
ere were no statistically signi cant differences in oxygen saturation-between the groups before and a er RSI (table 5) .
ere were no signi cant di erences be-tween groups in serum potassium level before RSI, but a er RSI the potassium level in the S-group was signi cantly higher in comparison to the R-group (Table 6 ). After the induction the potassium level increased signi cantly in the S-group and statistically signi cantly decreased in the R-group. ere were no signi cant di erences between groups in serum myoglobin level before and a er RSI, but a er RSI serum myoglobin level increased in the S-group (which was not statistically signi cant) and statistically signi cantly decreased in the R-group (Table 6) . Legend: e overall intubating conditions were graded excellent if all observed parameters were excellent. If the observed parameters were good and excellent the intubating conditions were graded good. If one or more parameters were poor, the intubating conditions were graded poor. Legend: mean value ± SD, *statistically signi cant, S-group = succinylcholine group, R-group = rocuronium group 
Intubating conditions
Excellent (n (%)) Good (n (%)) Poor (n (%)) 12 (80%) 3 (20%) 0 (0%) 6 (40%) 9 (60%) 0 (0%) 0.025* Legend: *statistically signi cant, S -group = succinylcholine group, R -group= rocuronium group Legend: *statistically signi cant, S-group = succinylcholine group, R-group= rocuronium group Legend: SBP -systolic blood pressure, HR -heart rate, RSI -rapid sequence intubation, DBP -diastolic blood pressure, SpO2 -pulse oximetry, SD -standard deviation, mean value ± SD *-statistically signi cant between groups **-statistically signi cant within group before and a er intubation
DISCUSSION
Our study aimed to compare the intubation conditions in 30 patients with bowel obstruction using two di erent muscle relaxants. We compared 1.5mg/kg succinylcholine and 1.2mg/kg rocuronium, which are the dosages that should provide rapid and best intubation conditions (23, 28) . Indirect laryngoscopy was performed 60 seconds a er the injection of muscle relaxant. All patients in both groups were successfully intubated in the rst attempt. We observed statistically signi cant better intubation conditions in patients in the S-group than in R-group (table 3) , according to the grading system score designed by Viby-Morgenson (22) . But comparing individual parameters, which determine intubating condition according to grading system score designed by Viby-Morgenson there were no statistically signi cantly differences between groups (Table 4 ). e main di erence between the groups was in the vocal cords position (Table 4 ). According to our study, rocuronium 1.2mg/kg b.w. allowed excellent and good intubation conditions which are accepted as clinically good enough for successful orotracheal intubation, without increased incidence of aspiration. Based on our results, we agree with the report by McCourt et al. that rocuronium 1mg/kg b.w. provides excellent and good intubation conditions, ful lling the conditions for acceptable intubation conditions in the patients who are undergoing elective or emergency surgery (24) . Luxen et al. also concluded that rocuronium, which has less side e ects and nearly the same intubation condition, can be a good replacement for succinylcholine in intubation of emergency department patients (25) . Contrary to our results, Perry J et al. in the Cochrane review in 2003 compared intubating conditions between rocuronium 0.6mg/kg and succinylcholine 1mg/kg. ey concluded the conditions were better when succinylcholine was used (26) . In the last Cochrane review in 2017 Tran et al. compared intubation conditions between rocuronium 1.2mg/kg and succinylcholine 1mg/kg and found no statistically signi cant di erence in intubation conditions. Despite their statistical results, they concluded due to succinylcholine shorter duration of action that succinylcholine created superior intubation conditions to rocuronium in achieving excellent and clinically acceptable intubating conditions and rocuronium should only be used as an alternative to succinylcholine (27) . Based on our results, we cannot agree with such conclusion, because rocuronium 1.2mg/ kg allowed excellent clinical intubation conditions and has more properties as an 'ideal' muscle relaxant for RSI than succinylcholine (28 -31) .
ere were no statistically signi cant differences in systolic blood pressure in both groups before and a er induction of anesthesia. A er the induction a statistically signi cant decrease in systolic blood pressure was observed in both groups. e decrease in systolic blood pressure was the consequence of induction drugs and mechanical ventilation a er induction. Heart rate decreased a er RSI in the Sgroup but not in the R-group with statistically signi cant di erences between the groups. Bradycardia is a well-known adverse e ect of succinylcholine, which can also in uence blood pressure, especially in critical ill patients undergoing emergency surgery due to bowel obstruction (9) . We observed an increase in potassium and myoglobin levels a er RSI in the S-group and slight decrease in the R-group. Change in potassium levels between the groups was statistically signi cant. Sabo et al. also concluded that succinylcholine was associated with a modest increase in potassium concentration and these changes were not seen a er rocuronium or sugammadex application (32) . In some patients with acquired pathologic state, hyperkalemic response to succinylcholine can be remarkable, causing ventricular brillation and death (33, 34) . In the literature some authors recommend precurarization with rocuronium before succinylcholine administration to reduce the incidence and severity of fasciculations and prevent an increase in serum potassium and myoglobin concentrations in adults and children (35) (36) (37) . But in our opinion, it is better to avoid using muscle relaxant with such life-threatening side e ects and risk for anaphylactic reaction, which is higher if compared to rocuronium and then, a er RSI, another intermediately acting neuromuscular blocking drug has to be used, with its own risk for anaphylactic reaction, to maintain neuromuscular block during abdominal surgery (38) . We have to emphasize that in our study in both groups of patients we did not observe any regurgitation or aspiration, which are the major life-threatening complications during RSI in patients with bowel obstruction.
CONCLUSION
e results in the present study indicate that rocuronium in RSI patients with bowel obstruction enables the same intubation conditions as succinylcholine and the same risk of aspiration which allows succinylcholine replacement and avoidance of its side e ects.
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